GCP
APLT

GSA Capital Partners’s Applied Therapeutics APLT Stock Holding History

GSA Capital Partners’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,994
Closed -$44K – 1628
2024
Q4 		$44K Buy
+50,994
New +$320K ﹤0.01% 1540
2024
Q3 		– Sell
-10,917
Closed -$51K – 1579
2024
Q2 		$51K Sell
10,917
-10,514
-49% -$49.8K ﹤0.01% 1564
2024
Q1 		$146K Buy
+21,431
New +$96.2K 0.01% 1452

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GSA Capital Partners's APLT Position: Q1 2025 in Review

GSA Capital Partners sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 50,994 shares — an estimated $44K sold.

GSA Capital Partners first reported a position in APLT in Q1 2024 and held it in 3 quarters. The position peaked at $146K in Q1 2024. 90 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

  • GSA Capital Partners reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
  • GSA Capital Partners sold 50,994 Applied Therapeutics shares in Q1 2025, an estimated $44K.
  • GSA Capital Partners first reported a position in Applied Therapeutics in Q1 2024 and held it in 3 quarters.
  • GSA Capital Partners's Applied Therapeutics position peaked at $146K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.